Coronavirus Latest News

Fauci says Covid-19 vaccine is possible by October but more likely for November – live

Leaders of the Moderna vaccine trial acknowledged one of the most important aspects of the effort will be to enroll diverse participants, including African Americans, Latinos and native Americans, as well as the elderly and disabled, all populations which disproportionately suffer from Covid-19.

However, finding diverse participants will be challenging. African American, Latino and Native American people may be less likely to enroll in the trial, because of mistrust of government science based on a history of abuse. The elderly and disabled may be less likely to enroll because of fear of the virus.

“We really are going to depend on that sense of volunteerism,” said NIH director Dr Francis Collins. “We’re going to be tracking this every week to see what the distribution [of diversity] looks like in the trial to make sure we’re achieving that kind of diversity.”

Dr Anthony Fauci said results of the trial were most likely going to begin being released in November, but would not rule out the possibility of an “October surprise”. Such a surprise would be proof of a safe and effective vaccine in the midst of the most highly anticipated presidential election in generations.

At 6:45am in Savannah, Georgia, the first American participant in a large experimental Covid-19 vaccine trial received a shot in the arm, the National Institutes of Health announced.

Researchers at Moderna, Inc. and the US National Institute of Allergy and Infectious Diseases (a branch of the NIH) hope to enroll 30,000 people for the final phase of safety and efficacy testing for the vaccine, including 15,000 people by the end of this week.

The trial will take place across 89 sites across America, with the potential for sites in South Africa and Brazil. The activated American sites will be focused in places with current Covid-19 outbreaks.

NIAID director Dr Anthony Fauci described the initiation of the Phase 3 trial as historic, and one of the fastest vaccine developments ever.

“We’re beginning a Phase 3 trial that is very quick – it certainly is the world’s record – when one thinks from the time of the sequence to a Phase 3 trial,” Fauci said.

He added: “There is no compromise at all in safety or scientific integrity.”

Read the original article at The Guardian

Related Articles

Back to top button